［1］ 中国医院协会血液净化中心分会血管通路工作组.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化,2019,18(6):365-381.
［2］ Sequeira A, Naljayan M, Vachharajani TJ. Vascular Access Guidelines: Summary, Rationale, and Controversies[J]. Tech Vasc Interv Radiol, 2017, 20(1): 2-8. DOI: 10.1053/j.tvir.2016.11.001.
［3］ Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review[J]. J Am Soc Nephrol, 2013, 24(3): 465-473. DOI: 10.1681/ASN.2012070643.
［4］ Beathard G A, Arnold P, Jackson J, et al. Aggressive treatment of early fistula failure.[J]. Kidney International,2003, 64(4):1487.
［5］ Abreo K , Buffington M , Sachdeva B . Angioplasty to promote arteriovenous fistula maturation and maintenance[J]. The Journal of Vascular Access, 2018:112972981876097.
［6］ Abreo K , Sequeira A . Role of stents in hemodialysis vascular access[J]. Journal of Vascular Access, 2018(3):1129729818761280.
［7］ Lee T , Misra S . New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes[J]. Clinical Journal of the American Society of Nephrology, 2016:CJN.02030216.
［8］ Riella M C , Roy-Chaudhury P . Vascular access in haemodialysis: strengthening the Achilles\" heel[J]. Nature Reviews Nephrology, 2013, 9(6):348-357.
［9］ 张炜晨, 张敏敏, 王梦婧, et al. 维持性血液透析患者自体动静脉内瘘血管钙化的研究进展[J]. 中华肾脏病杂志, 2018, 34(5):391-395.
［10］ Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, Heffelfinger S, Arend L: Cellular phenotypes in human stenotic lesions from hemodialysis vascular access. Nephrol Dial Transplant 24: 2786–2791, 2009
［11］ Ierardi Anna Maria, Franchin Marco, Fontana Federico et al. Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts.[J] .Radiol Med, 2017, 122: 69-76.
［12］ Lee, T. & Roy?Chaudhury,P.Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv. Chronic Kidney Dis. 16,329–338 (2009).
［13］ Lee, T. et al. Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol. Dial. Transplant. 26, 2264–2270 (2011).
［14］ Wasse, H. et al. Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J. Vasc. Access 13, 168–174 (2012).
［15］ Langer, S. et al. Chronic kidney disease aggravates arteriovenous fistula damage in rats.Kidney Int. 78, 1312–1321 (2010)
［16］ Kitrou P , Papasotiriou M , Katsanos K , et al. Recent developments in endovascular interventions to sustain vascular access patency in haemodialysis patients[J]. Nephrology Dialysis Transplantation, 2018.
［17］ 靖永胜, 王小平, 刘芳, et al. 动静脉内瘘功能障碍病理及发病机制的研究进展[J]. 中华肾脏病杂志, 2017, 33(04):318-320.
［18］ 王立华, 姜埃利, 魏芳. 动静脉内瘘建立后的血流动力学变化[J]. 中华肾脏病杂志, 2015, 31(10):797-800.
［19］ Franzoni Marco,Cattaneo Irene,Longaretti Lorena et al. Endothelial cell activation by hemodynamic shear stress derived from arteriovenous fistula for hemodialysis access.[J] .Am. J. Physiol. Heart Circ. Physiol., 2016, 310: H49-59.
［20］ Janeckova J , Bachleda P , Utikal P , et al. Surgical revision vs. stent-graft to treat venous anastomosis stenosis following surgical thrombectomy of hemodialysis grafts[J]. International angiology: a journal of the International Union of Angiology, 2018, 37(4).
［21］ Ioannis B , Georgia K , Nikolaos D , et al. A Review of Percutaneous Transluminal Angioplasty in Hemodialysis Fistula[J]. International Journal of Vascular Medicine, 2018, 2018:1-5.
［22］ Vorwerk D, Gunther RW, Schurmann K, Sieberth HG. Use of a cutting balloon for dilatation of a resistant venous stenosis of a hemodialysis fistula. Cardiovasc Intervent Radiol 1995; 18:62–64.
［23］ Vascular Access 2006 Work Group. KDOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48: S176–S247.
［24］ Wu C C , Lin M C , Pu S Y , et al. Comparison of Cutting Balloon versus High-Pressure Balloon Angioplasty for Resistant Venous Stenoses of Native Hemodialysis Fistulas[J]. Journal of vascular and interventional radiology : JVIR, 2008, 19(6):877-883.
［25］ Dariushnia SR, Walker TG, Silberzweig JE et al. Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit. J Vasc Interv Radiol 2016; 27: 1518–1530
［26］ 詹申[1], 杨涛[1], 张丽红[1], et al. 血液透析动静脉内瘘狭窄的介入治疗[J]. 中国血液净化, 2014, 13(8):595-597.
［27］ Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. J Vasc Surg. 2016;64:1400e1410.e1.
［28］ Karnabatidis D, Kitrou P. Drug eluting balloons for resistant arteriovenous dialysis access stenosis.[J]. Journal of Vascular Access, 2017, 18(1_suppl):88-91.
［29］ 郑全,杨建泉,罗建方,叶智明.影响经皮穿刺腔内血管成形术治疗动静脉内瘘狭窄术后通畅率的因素分析[J].岭南心血管病杂志,2018,24(5):561-566.
［30］ Aftab S A , Tay K H , Irani F G , et al. Randomized Clinical Trial of Cutting Balloon Angioplasty versus High-Pressure Balloon Angioplasty in Hemodialysis Arteriovenous Fistula Stenoses Resistant to Conventional Balloon Angioplasty[J]. Journal of Vascular and Interventional Radiology, 2014, 25(2):190-198.
［31］ Kitrou P , Spiliopoulos S , Karnabatidis D , et al. Cutting balloons, covered stents and paclitaxel-coated balloons for the treatment of dysfunctional dialysis access[J]. Expert Review of Medical Devices, 2016, 13(12):1119-1126.
［32］ Saleh HM, Gabr AK, Tawfik MM, et al. randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses. J Vasc Surg. 2014;60(3):735–740
［33］ Rasuli P, Chennur VS, Connolly MJ, et al. Randomized trial comparing the primary patency following cutting versus high-pressure balloon angioplasty for treatment of de novo venous stenoses in hemodialysis arteriovenous fistulae. J Vasc Interv Radiol. 2015;26 (12):1840-6.e1.
［34］ Khawaja A Z , Cassidy D B , Shakarchi J A , et al. Systematic Review of Drug Eluting Balloon Angioplasty for Arteriovenous Haemodialysis access Stenosis[J]. The Journal of Vascular Access, 2016, 17(2):103-110.
［35］ Kennedy S A, Mafeld S, Baerlocher M O, et al. Drug-Coated Balloon Angioplasty in Hemodialysis Circuits: A Systematic Review and Meta-Analysis[J]. Journal of Vascular and Interventional Radiology.
［36］ 李楠, 曾妮, 陈斌, et al. 裸支架与覆膜支架植入治疗血液透析患者中心静脉完全闭塞的临床疗效比较[J]. 中华肾脏病杂志, 2019, 35(3):198-203.
［37］ Vesely T , Davanzo W , Behrend T , et al. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts[J]. Journal of Vascular Surgery, 2016:S0741521416301756.
［38］ 王宾. 血液透析通路狭窄相关问题介入治疗进展[J]. 国际医学放射学杂志, 2017(3).
［39］ Peden E K . Role of Stent Grafts for the Treatment of Failing Hemodialysis Accesses[J]. Seminars in Vascular Surgery, 2011, 24(2):119-127.
［40］ Quaretti P, Galli F, Moramarco LP, et al. Stent grafts provided superior primary patency for central venous stenosis treatment in comparison with angioplasty and bare metal stent: a retrospective single center study on 70 hemodialysis patients[J]. Vasc Endovascular Surg, 2016,50:221-230
［41］ Hu H , Wu Z , Zhao J , et al. Stent graft placement versus angioplasty for hemodialysis access failure: a meta-analysis[J]. Journal of Surgical Research, 2018, 226:82-88.
［42］ Hu H , Wu Z , Zhao J , et al. Stent graft placement versus angioplasty for hemodialysis access failure: a meta-analysis[J]. Journal of Surgical Research, 2018, 226:82-88.
［43］ Neuen B L , Gunnarsson R , Webster A C , et al. Predictors of Patency after Balloon Angioplasty in Hemodialysis Fistulas: A Systematic Review[J]. Journal of Vascular and Interventional Radiology, 2014, 25(6):917-924.
［44］ Romann Alexandra,Beaulieu Monica C,Rhéaume Pascal et al. Risk factors associated with arteriovenous fistula failure after first radiologic intervention.[J] .J Vasc Access, 2016, 17: 167-74.
［45］ Rajan D K, Bunston S, Misra S, et al. Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty--are there clinical predictors of patency?. [J].Radiology, 2004, 232(2):508-515.
［46］ Wu CC, Wen SC, Yang CW, Pu SY, Tsai KC, Chen JW. Baseline plasma glycemic profiles but not inflammatory biomarkers predict symptomatic restenosis after angioplasty of arteriovenous fistulas in patients with hemodialysis. Atherosclerosis 2010; 209:598–600.
［47］ Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).Am J Kidney Dis 2002; 40:1255–1263.
［48］ Doi S, Masaki T, Shigemoto K, Harada S, Yorioka N. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients. Ther Apher Dial 2008; 12:232–236.
［49］ Heye S, Maleux G, Vaninbroukx J, et al. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. [J].European Journal of Radiology, 2012, 81(9):2298-2303
